| Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature medicine 29 (10), 2438-2457, 2023 | 118 | 2023 |
| Identification of autoantibody-negative autoimmune type 2 diabetic patients BM Brooks-Worrell, JL Reichow, A Goel, H Ismail, JP Palmer Diabetes care 34 (1), 168-173, 2011 | 106 | 2011 |
| β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis C Evans-Molina, EK Sims, LA DiMeglio, HM Ismail, AK Steck, JP Palmer, ... JCI insight 3 (15), 2018 | 93 | 2018 |
| Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial J Ware, CK Boughton, JM Allen, ME Wilinska, M Tauschmann, L Denvir, ... The Lancet Digital Health 4 (4), e245-e255, 2022 | 69 | 2022 |
| A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with … Diabetes Care 44 (2), 464-472, 2021 | 55 | 2021 |
| The shape of the glucose response curve during an oral glucose tolerance test: forerunner of heightened glycemic failure rates and accelerated decline in β-cell function in TODAY S Arslanian, L El Ghormli, J Young Kim, F Bacha, C Chan, HM Ismail, ... Diabetes Care 42 (1), 164-172, 2019 | 47 | 2019 |
| ISPAD Clinical Practice Consensus Guidelines 2022: management of cystic fibrosis‐related diabetes in children and adolescents KL Ode, M Ballman, A Battezzati, A Brennan, CL Chan, S Hameed, ... Pediatric diabetes 23 (8), 1212, 2022 | 42 | 2022 |
| The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes HM Ismail, P Xu, IM Libman, DJ Becker, JB Marks, JS Skyler, JP Palmer, ... Diabetologia 61 (1), 84-92, 2018 | 42 | 2018 |
| Consensus guidance for monitoring individuals with islet autoantibody–positive pre-stage 3 type 1 diabetes M Phillip, P Achenbach, A Addala, A Albanese-O’Neill, T Battelino, KJ Bell, ... Diabetes Care 47 (8), 1276-1298, 2024 | 34 | 2024 |
| The influence of body mass index and age on C‐peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial‐type 1 JM Sosenko, S Geyer, JS Skyler, LE Rafkin, HM Ismail, IM Libman, YF Liu, ... Pediatric diabetes 19 (3), 403-409, 2018 | 28 | 2018 |
| Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: implications for current staging … BM Nathan, MJ Redondo, H Ismail, L Jacobsen, EK Sims, J Palmer, ... Diabetes Care 45 (2), 311-318, 2022 | 26 | 2022 |
| Evaluation of short stature in children H Ismail, K Ness Pediatric Annals 42 (11), e227-e232, 2013 | 26 | 2013 |
| One-hour oral glucose tolerance tests for the prediction and diagnostic surveillance of type 1 diabetes KM Simmons, JM Sosenko, M Warnock, S Geyer, HM Ismail, ... The Journal of Clinical Endocrinology & Metabolism 105 (11), e4094-e4101, 2020 | 24 | 2020 |
| Self-rated health and factors influencing responses among young Egyptian type 1 diabetes patients H Ismail BMC public health 11, 1-7, 2011 | 23 | 2011 |
| Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report H Ismail Cases Journal 2, 1-4, 2009 | 21 | 2009 |
| Survey of personalized learning software systems: A taxonomy of environments, learning content, and user models H Ismail, N Hussein, S Harous, A Khalil Education Sciences 13 (7), 741, 2023 | 18 | 2023 |
| Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review JL Felton, KJ Griffin, RA Oram, C Speake, SA Long, S Onengut-Gumuscu, ... Communications medicine 3 (1), 130, 2023 | 17 | 2023 |
| Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trial DJ Wexler, IH De Boer, A Ghosh, N Younes, I Bebu, SE Inzucchi, ... JAMA internal medicine 183 (7), 705-714, 2023 | 16 | 2023 |
| The pathological evolution of glucose response curves during the progression to type 1 diabetes in the TrialNet Pathway to Prevention Study HM Ismail, MA Cleves, P Xu, IM Libman, DJ Becker, JB Marks, JS Skyler, ... Diabetes Care 43 (11), 2668-2674, 2020 | 13 | 2020 |
| Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review JL Felton, MJ Redondo, RA Oram, C Speake, SA Long, ... Communications medicine 4 (1), 66, 2024 | 12 | 2024 |